Avalo Therapeutics, Inc. earnings per share and revenue

AVTX earnings per share for the last quarter are -2.30 USD whereas the estimation was -0.17 USD which accounts for -1266.34% surprise. Company revenue for the same period amounts to 200.00 k USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -1.18 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of AVTX earnings per share and revenue dynamics.